Seeing Is Believing Video
The white colored insects flying around in the video below
are mosquitoes attacking the Arctic Mosquito Killing System(MKS)!

This video was shot with NIGHT VISION! The light in
the video is invisible to mosquitoes.

1.573.353.8021
Guaranteed Financing!
Protect your family
for
as low as $40 per month!
$0 Down Payment!

Arctic Mosquito Killing System


DECLARED BY PHD ENTOMOLOGISTS TO BE THE VERY BEST
MOSQUITO CONTROL SOLUTION EVER DEVELOPED


DEVELOPED WITH TECHNICAL ASSISTANCE FROM NASA
"Scientific breakthrough in mosquito control"
Patents: #6,050,025 #5,595,018 #6,568,124 & Patents Pending

nasa spinoff mosquito control
Read about our Mosquito Killing System from NASA
Click Here

 

Quick Fact #1

No other products or machines on the market can kill as many mosquitoes or reduce mosquito populations in a one-acre area as effectively or quickly as the Mosquito Killing System. 



 

NEED HELP
CALL NOW
1.573.353.8021

 

Arctic Mosquito
Killing System


W/Stand & CO2 Tank
FREE SHIPPING
USA Only
International Orders call for shipping quotes.

$1195.00

Easy financing terms available with monthly payments as low as $40.  Subject to credit approval.
$1195.00


Encephalitis Information...

  • St. Louis Encephalitis

  • Japanese Encephalitis

  • Eastern Equine Encephalitis

  • La Crosse Encephalitis

  • Western Equine Encephalitis
     

    St. Louis Encephalitis
    Q.
    How do people get St. Louis encephalitis?
    A. By the bite of a mosquito (primarily the Culex species) that become infected with St. Louis encephalitis virus (a flavivirus antigenically related to Japanese encephalitis virus).

    Q. What is the basic transmission cycle?
    A. Mosquitoes become infected by feeding on birds infected with the St. Louis encephalitis virus. Infected mosquitoes then transmit the St. Louis encephalitis virus to humans and animals during the feeding process. The St. Louis encephalitis virus grows both in the infected mosquito and the infected bird, but does not make either one sick.

    Q. Could you get the St. Louis encephalitis from another person?
    A. No, St. Louis encephalitis virus is NOT transmitted from person-to-person. For example, you cannot get the virus from touching or kissing a person who has the disease, or from a health care worker who has treated someone with the disease.

    Q. Could you get St. Louis encephalitis directly from birds or from insects other than mosquitoes?
    A. No. Only infected mosquitoes can transmit St. Louis encephalitis virus.

    Q. What are the symptoms of St. Louis encephalitis?
    A. Mild infections occur without apparent symptoms other than fever with headache. More severe infection is marked by headache, high fever, neck stiffness, stupor, disorientation, coma, tremors, occasional convulsions (especially in infants) and spastic (but rarely flaccid) paralysis.

    Q. What is the incubation period for St. Louis encephalitis?
    A. Usually 5 to 15 days.

    Q. What is the mortality rate of St. Louis encephalitis?
    A. Case-fatality rates range from 3% to 30% (especially in the aged).

    Q. How many cases of St. Louis encephalitis occur in the U.S.?
    A. Since 1964 there have been 4,478 reported human cases of St. Louis encephalitis, with an average of 128 cases reported annually.

    Q. How is St. Louis encephalitis treated?
    A. There is no specific therapy. Intensive supportive therapy is indicated.

    Q. Is the disease seasonal in its occurrence?
    A. In temperate areas of the United States, St. Louis encephalitis cases occur primarily in the late summer or early fall. In the southern United States where the climate is milder St. Louis encephalitis can occur year round.

    Q. Who is at risk for getting St. Louis encephalitis?
    A. All residents of areas where active cases have been identified are at risk of getting St. Louis encephalitis.

    Q. Where does St. Louis encephalitis occur?
    St. Louis encephalitis outbreaks can occur throughout most of the United States. The last major epidemic of St. Louis encephalitis occurred in the Midwest from 1974-1977. During that outbreak, over 2,500 cases in 35 states were reported to the CDC. Currently, outbreaks of St. Louis encephalitis have been limited in size (usually <30 cases), although the potential still exists for epidemic St. Louis encephalitis. The most recent outbreak of St. Louis encephalitis occurred in New Orleans, Louisiana in 1999, with 20 reported cases.

    Q. Is there a vaccine against St. Louis encephalitis?
    A. No.

     

    Japanese Encephalitis
    Japanese encephalitis is a common mosquito-borne viral encephalitis found in Asia. Most infections are asymptomatic, but if clinical illness develops, the case-fatality rate can be as high as 30%. Neuropsychiatric sequelae are reported in 50% of survivors. In endemic areas, children are at greatest risk of infection; however, multiple factors such as occupation, recreational exposure, gender (possibly reflecting exposure), previous vaccination, and naturally acquired immunity alter the potential for infection and illness. A higher case-fatality rate is reported in the elderly, but serious sequelae are more frequent in the very young, possibly because they are more likely to survive a severe infection.

    Japanese encephalitis virus is transmitted chiefly by the bites of mosquitoes in the Culex vishnui complex; the vector species depends on the specific geographic area. In China and many endemic areas in Asia, C. tritaeniorhyncus is the principal vector. This species feeds outdoors beginning at dusk and during evening hours until dawn; it has a wide host range, including domestic animals, birds, and humans. Larvae are found in flooded rice fields, marshes, and small stable collections of water around cultivated fields. In temperate zones, the vectors are present in greatest numbers from June through September and are inactive during winter months. Swine and certain species of wild birds function as viremic amplifying hosts in the transmission cycle.


    Occurrence...

    Habitats supporting the transmission cycle of Japanese encephalitis virus are principally in rural, agricultural locations. In many areas of Asia, however, the appropriate ecologic conditions for virus transmission occur near or occasionally within urban centers. Transmission is seasonal and occurs in the summer and autumn in the temperate regions of China, Japan, Korea, and eastern areas of Russia. Elsewhere, seasonal patterns of disease are more extended or vary with the rainy season and irrigation practices.
     

    Risk for Travelers...

    The risk to short-term travelers and those who confine their travel to urban centers is very low. Expatriates and travelers living for prolonged periods in rural areas where Japanese encephalitis is endemic or epidemic are at greatest risk. Travelers with extensive unprotected outdoor, evening, and nighttime exposure in rural areas, such as might be experienced while bicycling, camping, or engaging in certain occupational activities, might be at high risk even if their trip is brief.

     

    Eastern Equine Encephalitis
    CLINICAL FEATURES

    • Symptoms range from mild flu-like
          illness to frank encephalitis, coma and
          death
       

    ETIOLOGIC AGENT

    • Eastern equine encephalitis virus,
          member of the family Togaviridae,
          genus Alphavirus.

    • Closely related to western and
          Venezuelan equine encephalitis
          viruses.


    COSTS

    • Total case costs range from $21,000 for
          transiently infected individuals to $3
          million for severely infected individuals

    • Insecticide applications can cost as
          much as $1.4 million depending on the
          size of area treated
      .


    TRANSMISSION

    • Mosquito-borne


    RISK GROUPS

    • Residents of endemic areas and visitors

    • Persons with outdoor work and
          recreational activities.


    SURVEILLANCE

    • National Notifiable Diseases
          Surveillance System.
       

    TRENDS

    • Risk exposure increases as population
          expands into endemic areas
       

    La Crosse Encephalitis

    CLINICAL FEATURES

    • Frank encephalitis progressing to
          seizures, coma; majority of infections
          are subclinical or result in mild illness.

       

    ETIOLOGIC AGENT

    • La Crosse virus - California serogroup
          virus in the family Bunyaviridae
      .
       

    INCIDENCE

    • Approximately 70 cases reported per
          year.
       

    SEQUELAE

    • Case-fatality ratio <1%

    • Hospitalization for CNS infection

    • Neurological sequelae that resolve
          within several years.
       

    COSTS

    • Short-term hospitalization to long-term
          care exceeding.

    • $450,000

    • Social costs from adverse effects on IQ
          and school performance
      .
       

    TRANSMISSION

    • Virus cycles in woodland habitats
          between the treehole mosquito (Aedes
          triseriatus
      ) and vertebrate hosts
          (chipmunks, squirrels)
      .

    • Virus survives winter in mosquito.

    • Vector uses artificial containers (tires,
          buckets, etc.) in addition to treeholes.
       

    RISK GROUPS

    • Children <16 years old: biological risk
          factor

    • Residence in woodland habitats
          environmental risk factor.
    • Containers at residence environmental
          risk factor.

    • Outdoor activities: behavioral risk factor.
       

    Western Equine Encephalitis

    CLINICAL FEATURES

    • Symptoms range from mild flu-like
          illness to frank encephalitis, coma and
          death

     

    ETIOLOGIC AGENT

    • Western equine encephalitis virus,
          member of the family Togaviridae,
          genus Alphavirus. Closely related to
          eastern and Venezuelan equine
          encephalitis viruses

     

    INCIDENCE

    • 639 confirmed cases in the U.S. since
         1964

     

    SEQUELAE

    • Mild to severe neurologic deficits in
          survivors

     

    COSTS

    • Total case costs range from $21,000 for
          transiently infected individuals to $3
          million for severely infected individuals

    • Insecticide applications can cost as
          much as $1.4 million depending on the
          size of area treated

     

    TRANSMISSION

    • Mosquito-borne

     

    RISK GROUPS

    • Residents of endemic areas and
          visitors.

    • Persons with outdoor work and
          recreational activities.

Quick Fact #2

Mosquitoes usually stay within 100 yards of their hatching site. Each mosquito caught is a female that can lay 300 eggs. Every 1,000 mosquitoes eliminated, reduces the population by 300,000.

 

 

 

 

NEED HELP
CALL NOW
1.573.353.8021


 

Arctic Midge / Mosquito Killing System


W/Stand & CO2 Tank
FREE SHIPPING
USA Only
International Orders call for shipping quotes.

$1295.00


Easy financing terms available with monthly payments as low as $40.  Subject to credit approval.
$1295.00


 


 

 


Midge & Mosquito Control, LLC
307 NW Gibson Rd
Lees Summit, MO 64063
US & International 1.573.353.8021

Copyright © 2007 All Rights Reserved / Arctic Products, Inc. / Sean Desmond/ Alvin Wilbanks

/ 2003 CDC Statistics / Belmont Test / Benefits / Return & Repair Policy / Capture Net / Choose MKS / CO2 Benefits /
/ CO2 Refill Stations / CO2 Test Results / Dengue Fever / Encephalitis / Entomologist / FAQ /
/ History / How The MKS Works / Home / Info Video / Installations / Malaria / Mosquito Traps /
/ Nasa Inventor Zaps Mosquitoes / Nasa Reference / Nasas Role / Nasa Target Mosquito /
/ Non Target Test Results / Not Competition / Osceola Reference / Placement /
/ Prepare Now / Probing MKS / Research / Rift Valley Fever / Seeing Is Believing /
/ Usage / USPS Test / West Nile / Yellow Fever / Dealers /